Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huawei Cui

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cell Reports. Medicine|October 2, 2024
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacyKua Liu, Lingkai Kong, Huawei Cui, et al.
Communications Medicine|March 17, 2026
Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8<sup>+</sup> T cellsLingkai Kong, Kua Liu, Yan Liu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cell Reports. Medicine|October 2, 2024
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacyKua Liu, Lingkai Kong, Huawei Cui, et al.
Communications Medicine|March 17, 2026
Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8<sup>+</sup> T cellsLingkai Kong, Kua Liu, Yan Liu, et al.
Pageof 2